Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix Intermittent Androgen Deprivation in Prostate Cancer
NCT00801242Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Dec 2008
- Primary completion
- Jun 2012
- Modality
- Peptides, Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of degarelix in prostate cancer (PCa), sponsored by Ferring Pharmaceuticals. Started Dec 2008; status: completed.
02
Drugs
degarelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00801242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00801242.